Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 Thalidomide in Crohn's disease.

× No keyword cloud information.

15 in total

Review 1. Immunomodulation by thalidomide and thalidomide analogues.

Authors: L G Corral; G Kaplan
Journal: Ann Rheum Dis Date: 1999-11 Impact factor: 19.103

2. Thalidomide reduces tumour necrosis factor alpha and interleukin 12 production in patients with chronic active Crohn's disease.

Authors: J Bauditz; S Wedel; H Lochs
Journal: Gut Date: 2002-02 Impact factor: 23.059

3. Secretion imbalance between tumour necrosis factor and its inhibitor in inflammatory bowel disease.

Authors: M Noguchi; N Hiwatashi; Z Liu; T Toyota
Journal: Gut Date: 1998-08 Impact factor: 23.059

Review 4. Thalidomide in gastrointestinal disorders.

Authors: A Bousvaros; B Mueller
Journal: Drugs Date: 2001 Impact factor: 9.546

5. Pomalidomide suppresses cerulein-induced acute pancreatitis in mice.

Authors: Ming Jen Tsai; Chinpiao Chen; Sung-Ho Chen; Yen Ta Huang; Ted H Chiu
Journal: J Gastroenterol Date: 2011-03-25 Impact factor: 7.527

6. Thalidomide induces mucosal healing in Crohn's disease: case report.

Authors: Márcio Rios Leite; Sandra Sousa Santos; André Castro Lyra; Jaciane Mota; Genoile Oliveira Santana
Journal: World J Gastroenterol Date: 2011-12-07 Impact factor: 5.742

Review 7. Maintenance of remission in Crohn's disease: current and emerging therapeutic options.

Authors: Matthew J Brookes; Jonathon R B Green
Journal: Drugs Date: 2004 Impact factor: 9.546

Review 8. Angiogenesis and vascular malformations: antiangiogenic drugs for treatment of gastrointestinal bleeding.

Authors: Juergen Bauditz; Herbert Lochs
Journal: World J Gastroenterol Date: 2007-12-07 Impact factor: 5.742

9. Pediatric Inflammatory Bowel Disease.

Authors:
Journal: Curr Treat Options Gastroenterol Date: 2000-10

10. Thalidomide costimulates primary human T lymphocytes, preferentially inducing proliferation, cytokine production, and cytotoxic responses in the CD8+ subset.

Authors: P A Haslett; L G Corral; M Albert; G Kaplan
Journal: J Exp Med Date: 1998-06-01 Impact factor: 14.307